Chowers Y - Search Results

1

Tailoring anti-TNF therapy in IBD: drug levels and disease activity.

Ben-Horin S, Chowers Y. Ben-Horin S, et al. Among authors: chowers y. Nat Rev Gastroenterol Hepatol. 2014 Apr;11(4):243-55. doi: 10.1038/nrgastro.2013.253. Epub 2014 Jan 7. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24393836 Review.

2

Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group.

Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, Reshef R, Odes S, Moshkovitz M, Bruck R, Eliakim R, Maoz E, Mittmann U. Bar-Meir S, et al. Among authors: chowers y. Gastroenterology. 1998 Oct;115(4):835-40. doi: 10.1016/s0016-5085(98)70254-9. Gastroenterology. 1998. PMID: 9753485 Clinical Trial.

3

Somatostatin through its specific receptor inhibits spontaneous and TNF-alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells.

Chowers Y, Cahalon L, Lahav M, Schor H, Tal R, Bar-Meir S, Levite M. Chowers Y, et al. J Immunol. 2000 Sep 15;165(6):2955-61. doi: 10.4049/jimmunol.165.6.2955. J Immunol. 2000. PMID: 10975802 Free article.

4

Increased levels of homocysteine in patients with Crohn's disease are related to folate levels.

Chowers Y, Sela BA, Holland R, Fidder H, Simoni FB, Bar-Meir S. Chowers Y, et al. Am J Gastroenterol. 2000 Dec;95(12):3498-502. doi: 10.1111/j.1572-0241.2000.03367.x. Am J Gastroenterol. 2000. PMID: 11151883

5

Disaccharides derived from heparin or heparan sulfate regulate IL-8 and IL-1 beta secretion by intestinal epithelial cells.

Chowers Y, Lider O, Schor H, Barshack I, Tal R, Ariel A, Bar-Meir S, Cohen IR, Cahalon L. Chowers Y, et al. Gastroenterology. 2001 Feb;120(2):449-59. doi: 10.1053/gast.2001.21202. Gastroenterology. 2001. PMID: 11159885

6

Clinical and demographic characterization of Jewish Crohn's disease patients in Israel.

Fidder HH, Avidan B, Lahav M, Bar-Meir S, Chowers Y. Fidder HH, et al. Among authors: chowers y. J Clin Gastroenterol. 2003 Jan;36(1):8-12. doi: 10.1097/00004836-200301000-00005. J Clin Gastroenterol. 2003. PMID: 12488699

7

Position statement: immunomodulator therapy for inflammatory Bowel disease.

Lavy A, Chowers Y, Odes HS, Eliakim R; Israel gastroenterology association. Lavy A, et al. Among authors: chowers y. Isr Med Assoc J. 2003 Mar;5(3):164-9. Isr Med Assoc J. 2003. PMID: 12725133 Free article. No abstract available.

8

Allicin inhibits spontaneous and TNF-alpha induced secretion of proinflammatory cytokines and chemokines from intestinal epithelial cells.

Lang A, Lahav M, Sakhnini E, Barshack I, Fidder HH, Avidan B, Bardan E, Hershkoviz R, Bar-Meir S, Chowers Y. Lang A, et al. Among authors: chowers y. Clin Nutr. 2004 Oct;23(5):1199-208. doi: 10.1016/j.clnu.2004.03.011. Clin Nutr. 2004. PMID: 15380914

9

The month of birth is linked to the risk of Crohn's disease in the Israeli population.

Chowers Y, Odes S, Bujanover Y, Eliakim R, Bar Meir S, Avidan B. Chowers Y, et al. Am J Gastroenterol. 2004 Oct;99(10):1974-6. doi: 10.1111/j.1572-0241.2004.40058.x. Am J Gastroenterol. 2004. PMID: 15447759

10

The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease.

Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, Bar-Meir S, Avidan B, Shinhar Y. Fidder H, et al. Among authors: chowers y. Am J Gastroenterol. 2005 Feb;100(2):338-43. doi: 10.1111/j.1572-0241.2005.40810.x. Am J Gastroenterol. 2005. PMID: 15667491

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results